
Heard in 9 episodes across 3 shows since Aug 2026
Sam Fazeli is Director of Research for Global Industries and a Senior Pharmaceuticals Analyst at Bloomberg Intelligence. He is known for his analysis of the biotechnology and pharmaceutical industries and serves as a non-executive director at Arecor Limited.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 5 |
| Sep 2026 | 0 |
| Oct 2026 | 3 |
| Nov 2026 | 1 |
Email alert
Email me when Sam Fazeli comes up on a podcast
One email a week at most, with the new episodes that mention Sam Fazeli. Free, no account needed, unsubscribe in one click.
What Sam Fazeli has said on podcasts
19 statements
AI can replace two or three contractors for some data-gathering tasks.
“i can displace two or three contractors, for instance, in some data gathering”
Open the episode · Episode 201 - October 30, 2026Listen at 14:48
Human review remains necessary to finalize AI-gathered data quality.
“I still need the human in the loop to finalize the quality of the data”
Open the episode · Episode 201 - October 30, 2026Listen at 14:56
A major Iran-related attack could raise oil prices and interest rates.
“a massive jump in oil prices could result in higher interest rates”
Open the episode · Episode 201 - October 30, 2026Listen at 28:14
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
9 episodes featuring Sam Fazeli, newest first
- Nov 16, 2026
Anthropic IPO tests AI trade as Nvidia faces mounting pressureBloomberg IntelligenceNov 16, 2026Guest - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026Guest - Oct 23, 2026
AI challenges biotech’s old company modelBiotech HangoutOct 23, 2026Guest - Oct 5, 2026
Freight consolidation meets the financing test for AI’s next buildoutBloomberg IntelligenceOct 5, 2026Guest - Aug 19, 2026
Moderna advances cancer vaccine as rail merger review resumesStock MoversAug 19, 2026Guest - Aug 19, 2026
Moderna vaccine news lifts shares as furniture sales disappointStock MoversAug 19, 2026